2m 2m 2m 2m 2m 2m 2m
LUCID DIAGNOSTCS (LUCD)
NASDAQ
$1.01+$0.02 (+2.31%)
Price as of Jul 14, 2026 6:29 PM EDT- $189.1MMarket Cap
- -15.29%1-Year Change
- Medical DevicesIndustry
LUCID DIAGNOSTCS (LUCD)
$1.01+$0.02 (+2.31%)
LUCD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.99 | ||
Change | -$0.009 (-0.89%) | ||
Open | $1.00 | ||
High | $1.02 | ||
Low | $0.97 | ||
Previous Close | $1.00 | ||
Volume | 1,086,580 | ||
30-Day Average Volume | 1,922,355 | ||
1-Week Change | -8.23% | ||
1-Month Change | 3.16% | ||
1-Year Change | -15.29% | ||
3-Year Change | -27.66% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 190.8M | ||
Total Assets | $34.1M | ||
Market Cap | $189.1M | ||
Enterprise Value | $186.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.3M | ||
Net Income | -$13.9M | ||
Free Cash Flow | -$12.3M | ||
EBIT | -$13.9M | ||
EBITDA | -$13.7M | ||
Net Working Capital | $2.0M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 148 | ||
P/B | 47 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue